Phlebotomy Test Quality Assurance and Quality Control 2 — Questions and Answers

Question 1: Which of the following BEST describes the purpose of a quality assurance (QA) program in a laboratory?

To ensure all laboratory equipment is calibrated monthly
To monitor and improve all processes affecting the quality and accuracy of patient test results (Correct answer)
To train new laboratory staff on equipment operation
To conduct random audits of phlebotomy technique only

Correct answer: To monitor and improve all processes affecting the quality and accuracy of patient test results

QA encompasses the entire system of monitoring, evaluating, and improving all laboratory processes—pre-analytical, analytical, and post-analytical—to ensure accurate, reliable results.

A laboratory quality assurance (QA) program is a comprehensive, ongoing system designed to ensure that all aspects of laboratory operations consistently produce accurate, reliable test results. QA encompasses: (1) Pre-analytical monitoring — phlebotomy technique, specimen rejection rates, turnaround time for collections, patient identification error rates; (2) Analytical monitoring — QC results, proficiency testing performance, calibration verification, instrument maintenance; (3) Post-analytical monitoring — critical value notification compliance, result TAT, transcription error rates, physician query rates; (4) Personnel competency assessment; (5) Document and procedure control; (6) Corrective and preventive action (CAPA) systems; (7) Patient complaint monitoring. QA differs from QC in scope: QC specifically monitors analytical accuracy and precision; QA monitors the entire system. CLIA requires QA programs for all certified laboratories, with specific monitoring indicators tracked and reviewed at defined intervals.

Question 2: A QC control value plots at +2.3SD on the Levey-Jennings chart. According to Westgard rules, this result is:

A rejection requiring immediate corrective action
A warning (1₂s violation)—investigate before running patient samples (Correct answer)
Within acceptable limits—no action required
An indication of random error requiring instrument recalibration

Correct answer: A warning (1₂s violation)—investigate before running patient samples

A value between ±2SD and ±3SD triggers the 1₂s warning rule—not an automatic rejection, but a signal to investigate before proceeding with patient testing.

In the Westgard multirule system: The 1₂s rule (one control >±2SD) is a WARNING rule, not a rejection rule. When a control value falls between ±2SD and ±3SD (as in this case, +2.3SD), it triggers the 1₂s warning. This means: (1) Do not automatically reject the run; (2) Investigate by examining the next QC control values to see if they also exceed limits; (3) Review the Levey-Jennings chart for trending patterns; (4) Apply other Westgard rules (2₂s, R4s, 4₁s) to determine if rejection is warranted; (5) If no other rules are violated and no obvious cause is found, patient results may be released with documentation. If the next control also exceeds ±2SD on the same side (2₂s rule), then reject. In a normally distributed dataset, 4.6% of values fall outside ±2SD by chance, so the 1₂s violation alone is not sufficient for rejection—it is a signal to be cautious and investigate.

Question 3: A laboratory is investigating a systematic positive bias in sodium results compared to proficiency testing. Which of the following is MOST likely to be the cause?

Random pipetting errors in individual samples
Expired control material causing erroneous results only in QC
Calibrator drift or incorrect calibration assignment (Correct answer)
Hemolysis in patient samples causing elevated sodium

Correct answer: Calibrator drift or incorrect calibration assignment

Systematic bias (consistently too high) in an electrolyte analyzer most commonly results from calibrator drift, where the reference solution's concentration has shifted, causing all results to be offset.

Systematic bias (all results consistently too high or too low) in analyte measurement is most commonly caused by calibration-related issues: (1) Calibrator drift — the actual concentration in the calibrator solution has changed over time (evaporation, degradation) while the assigned value remains the same; (2) Wrong calibrator lot number assignment; (3) Evaporation of the calibrator (open tube, high concentration); (4) Matrix effect — calibrator composition doesn't truly match patient samples; (5) Electrode drift in ion-selective electrode (ISE) analyzers (common for Na, K, Cl). Hemolysis causes sodium dilution (falsely lower, not higher). Random pipetting errors produce random, not systematic, errors. Expired control material might produce wrong QC values but wouldn't cause systematic bias in patient results. Calibration verification and calibrator lot change investigation are the first steps when systematic bias is found in proficiency testing comparison.

Question 4: Proficiency testing (PT) is an EXTERNAL quality assessment tool that primarily evaluates:

Individual phlebotomist's specimen collection technique
The accuracy of a laboratory's test methods by comparing results with peer laboratories (Correct answer)
Daily QC performance over a 30-day period
The laboratory's compliance with OSHA safety regulations

Correct answer: The accuracy of a laboratory's test methods by comparing results with peer laboratories

Proficiency testing sends unknown specimens to a laboratory and compares its results against peer laboratory results and target values to assess method accuracy.

Proficiency testing (PT) or external quality assessment (EQA) is a mandatory component of CLIA certification for most non-waived tests. PT programs (such as CAP, AACC, AAFP) periodically send preserved biological specimens with unknown values to enrolled laboratories. The laboratory analyzes the specimen exactly as it would a patient specimen and reports the result. The PT organization then compares the laboratory's result to: (1) The target value (assigned value or consensus of reference methods); (2) Peer laboratory results (same method/instrument); (3) All-laboratory results. Acceptable performance is defined by the laboratory's result falling within a specified range (e.g., ±2 standard deviations of the peer mean, or a defined acceptable error percentage). PT failures require mandatory investigation and corrective action. Successful PT performance is required for CLIA certification renewal. PT specifically evaluates analytical accuracy—it does not assess pre-analytical collection technique.

Question 5: A laboratory QA review finds that the specimen rejection rate for hemolysis has increased from 2% to 8% over the past month. The FIRST step in the quality improvement process is to:

Immediately retrain all phlebotomists on hemolysis prevention
Investigate the root cause by analyzing rejection data by phlebotomist, time of day, and patient unit (Correct answer)
Report the increase to the medical director and close the investigation
Accept the new rate as reflective of sicker patients in the hospital

Correct answer: Investigate the root cause by analyzing rejection data by phlebotomist, time of day, and patient unit

Root cause analysis must precede intervention—the rejection rate data must be stratified to identify where and why the increase is occurring before choosing the appropriate corrective action.

An increase in specimen rejection rate is a quality indicator that triggers a quality improvement (QI) investigation. The proper process: (1) Root cause analysis — stratify the rejection data by phlebotomist/nurse collector, patient care unit, time of day, collection method (venipuncture vs. IV draw), patient population, and specimen type; (2) Identify patterns — is the increase concentrated in one phlebotomist? One unit? One shift? One tube type? A specific patient population (PICC lines, IVs)? A new supply lot?; (3) Form a hypothesis about the cause; (4) Implement targeted corrective action based on findings (targeted retraining, equipment change, process change); (5) Reassess after intervention to verify improvement. Universal retraining before root cause identification is inefficient—if the problem is in IV-drawn specimens from the ED, retraining all phlebotomists doesn't fix it. Data-driven root cause analysis is the foundation of evidence-based quality improvement.

Question 6: Which of the following represents a POST-ANALYTICAL quality concern in phlebotomy and laboratory practice?

Using the wrong vacuum tube for the ordered test
Failing to notify the provider of a critical value within the required timeframe (Correct answer)
Centrifuging a specimen at the wrong speed
Mislabeling a specimen tube at the bedside

Correct answer: Failing to notify the provider of a critical value within the required timeframe

Critical value notification failure is a post-analytical error—it occurs after the result is generated, in the communication/reporting phase.

Laboratory errors by phase: Pre-analytical (before measurement): wrong tube, mislabeling, hemolysis, wrong collection time. Analytical (during measurement): QC failure, calibration error, reagent problems, centrifuge error. Post-analytical (after measurement and result generation): (1) Critical value notification failure — failing to call or document notification of life-threatening results (glucose <40, K+ >6.5, etc.) within the required timeframe is a serious patient safety and regulatory violation; (2) Transcription errors when entering results; (3) Delayed result reporting; (4) Wrong reference ranges applied; (5) Misinterpretation of reference intervals; (6) Failure to flag hemolyzed/icteric/lipemic specimens that affect results; (7) Report sent to wrong provider. JCAHO and CLIA mandate that critical values be communicated to responsible caregivers within defined timeframes (typically 30–60 minutes), with documentation of who was notified and when.

Question 7: A laboratory implements a new centrifuge protocol and notices gel separator tubes processed under the new protocol have serum with red cell contamination visible above the gel barrier. This is MOST likely due to:

Tubes being centrifuged at too high a speed for too long
Centrifugation at insufficient speed or time, preventing complete separation (Correct answer)
Tubes being stored upright instead of inverted during centrifugation
An error in the QC of the tube itself

Correct answer: Centrifugation at insufficient speed or time, preventing complete separation

Inadequate centrifuge speed (g-force) or insufficient time fails to drive cells through the gel barrier, leaving them in the serum layer above the gel.

Gel separator tubes (SST/GST) contain a thixotropic gel that, during centrifugation, migrates between the serum/plasma layer and the cellular components based on its intermediate density. For proper separation: the centrifuge must achieve the manufacturer-specified g-force (typically 1,000–1,300 g for most SST tubes) for the required time (typically 10 minutes). If the centrifuge speed is too low or the time is too short, the gel does not migrate completely, allowing red blood cells to remain above the gel in contact with the serum. This causes falsely elevated potassium, LDH, and other intracellular components as RBCs continue to metabolize and lyse. The solution is to recalibrate the centrifuge to the correct RPM for the tube type and verify the time. Excessive speed and time can cause hemolysis from shear forces. Correct centrifuge validation for each tube brand and type is a laboratory QA requirement.

Question 8: A laboratory's QA program identifies that STAT order turnaround times frequently exceed the 60-minute target. The MOST effective initial intervention is to:

Purchase additional laboratory analyzers immediately
Map the current STAT process to identify the specific step causing delay (Correct answer)
Mandate that all STAT specimens be run before routine tests without exception
Increase the STAT TAT target to 90 minutes to reduce perceived failures

Correct answer: Map the current STAT process to identify the specific step causing delay

Process mapping visualizes each step in the STAT workflow, identifying the specific bottleneck causing delays before implementing targeted, effective interventions.

When TAT targets are consistently missed, the quality improvement approach is to map the existing process (value stream mapping or process flowcharting) before implementing solutions. Process mapping identifies: (1) Each step in the STAT process (order entry → phlebotomy dispatch → draw time → transport time → receiving → centrifugation → analytical time → result verification → reporting); (2) The time spent at each step; (3) Which step(s) are causing the greatest delays. Once the bottleneck is identified (e.g., 35 of the 60 minutes are spent waiting for transport after collection), targeted interventions can be implemented (dedicated STAT transport runner, pneumatic tube installation, bedside POCT). Buying new analyzers only helps if the analyzer processing time is the bottleneck (often it isn't). Increasing the target is a metric manipulation that doesn't improve patient care. Mandating STAT priority may help but without knowing the bottleneck, may not address the real problem.

Phlebotomy Test Quality Assurance and Quality Control 2

Which of the following BEST describes the purpose of a quality assurance (QA) program in a laboratory?

🃏 Study This Quiz as Flashcards →

📚 Want to go deeper? Read the Full Exam Study Guide →